Distress Over Dividend Delays

Why are we waiting? Addressing dividend delays amongst UK blue chip companies

Fundamental Tracker Investment Management 10 October, 2012 | 6:00AM
Facebook Twitter LinkedIn

This article is part of Morningstar's "Perspectives" series, which is a series of articles written by third-party contributors.

As an investor, it would be fair to operate on the premise that the lion’s share of investment returns from the stock market are derived from the compounding effect of the reinvestment of dividends. The evidence from the Barclays Equity Gilt Study suggests this accounts for as much as 90% of the total returns from the UK market over the longer term.  The importance of dividends is recognised in well-known valuation methods such as the Gordon Growth Model, which estimates the present value of future dividends to derive company valuations.

Given the importance placed on dividends ... it is strange that so little attention has been paid to the way many companies delay releasing dividend payments to their shareholders

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
AstraZeneca PLC8,845.00 GBP0.00Rating
Aviva PLC400.00 GBP0.00Rating
Barclays PLC183.74 GBP0.00Rating
BT Group PLC158.45 GBP0.00Rating
Centrica PLC54.02 GBP0.00Rating
Imperial Brands PLC1,544.00 GBP0.00Rating
Reckitt Benckiser Group PLC5,853.00 GBP0.00Rating
Royal Dutch Shell PLC B1,536.44 GBP0.53Rating
SSE PLC1,612.17 GBP-1.00Rating
Tesco PLC255.47 GBP-0.79Rating
Unilever PLC3,989.00 GBP-0.03Rating
Vodafone Group PLC113.26 GBP-0.47Rating
VT Munro Smart Beta UK A Acc Retail129.07 GBP-0.34Rating

About Author

Fundamental Tracker Investment Management  is dedicated to the investment philosophy of constructing tracker funds using measures other than price. The company runs one fund, The Munro UK Dividend Fund, and uses fundamental measures to assess companies.

© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement